Navigation Links
In 2008, Ipsogen Reinforced its Leadership in Molecular Diagnosis and Monitoring of Leukemia
Date:1/12/2009

MARSEILLE, France, January 12 /PRNewswire-FirstCall/ -- IPSOGEN SA (Alternext - FR0010626028 - ALIPS), a cancer profiler that develops and markets molecular diagnostic products for leukemia and breast cancer has launched 3 new products during the fourth quarter of 2008, that expand its leukemia molecular diagnostic portfolio:

    - FusionQuant BCR-ABL IVD kit, used in the the detection and monitoring
      of chronic myeloid leukemias (CML), is a new CE marked expanded
      version of our existing product. The new IVD kit now provides all the
      necessary components in one package adding convenience and efficiency
      in the lab. The improved kit will also support the much needed test
      standardisation required for proper disease monitoring

    - ProfileQuant CLLU1, in chronic lymphocytic leukemia (CLL).
      This research kit provides prognostic information, and has the
      potential to play a significant role in the monitoring of this disease.

    - MutaScreen MPL, a research kit for the detection of MPL mutations in
      JAK2 negative myeloproliferative neoplams (MPN), is a significant
      addition to the MPD family of products that Ipsogen offers.

These 3 new tests exemplify Ipsogen's strategy of (i) introducing technological and scientific innovation to address unmet diagnostic needs, and (ii) rapidly translating scientific discoveries into patient bedside tools, in line with the ultimate objective of enabling better and more personalised disease management.

"In the last quarter of 2008, we launched 3 new products. With 21 kits now in distribution, of which 10 are CE marked, Ipsogen's molecular diagnostic portfolio covers a significant range of the leukemia spectrum. These new products will help hematologists refine and improve treatment strategies" says Stephane Debono, COO and in charge of product planning..

Vincent Fert, CEO, concludes: 'These
'/>"/>

SOURCE Ipsogen SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance
2. Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets
3. Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155
4. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
5. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
6. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
7. Sales of Stem Cell Products Expected to Reach $87 Million in 2008, Leading Medical Industry Analyst Says
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
10. Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy
11. Sparta Systems Demonstrates Global Enterprise Quality Management Leadership at TrackWise(R) Connection User Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 Why did Stephen Hawking become ... so instantly recognizable? Why have they become icons to ... author Hilton Ratcliffe seeks out the answers to those ... to do with science. In " Stephen Hawking Smoked ... 21, 2014), Ratcliffe puts it plainly: , “It ...
(Date:11/21/2014)... 2014 2014 Deep Research Report ... in-depth research report on the transformer market. The ... application, and industry chain structure as well as ... analysis, including China’s domestic market as well as ... situation analysis. The report also covers information on ...
(Date:11/21/2014)... 20, 2014 /CNW/ - Aequus Pharmaceuticals Inc. (the ... it has closed a brokered private placement offering ... C$3.7 million.  Cormark Securities Inc. and Clarus Securities ... Offering for a syndicate of agents that also ... (collectively the "Agents"). Concurrently with the Brokered Offering, ...
(Date:11/21/2014)... GUELPH, ON , Nov. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: ... month and nine month periods ended September 30, 2014.  Biorem,s complete ... SEDAR ( www.sedar.com ). Financial Summary:Three-months ended ... CDN$,000 except per share data) , 2014 , ... , 2,282 , 5,281 , 6,715 ...
Breaking Biology Technology:“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 2International Transformer Industry - Analysis on Applications, Development & Forecasts Now Available at ReportsnReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3
... , , TUSTIN, Calif., ... announced that it will release its financial results for the second ... a.m. EST and will host a conference call and webcast to ... , Peregrine,s senior management will discuss financial results for the second ...
... , ... Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology ... Diabetic,Foot Care in New Delhi, India, November 22, 2009. Beike is ... The conference, organized by the Indian Podiatry Association (IPA), ...
... , NEW YORK, Dec. 2 Reportlinker.com ... in its catalogue: , Neurostimulation - A Global ... The world neurostimulation market stands enthused by the growing ... age-related diseases such as, Parkinson,s, and Alzheimer,s disease. Widespread ...
Cached Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
(Date:11/4/2014)... LAKE CITY, Nov. 5, 2014 – University of Utah ... enzymes to help jet fuel produce electricity without needing ... be used to power portable electronics, off-grid power and ... online today in the American Chemical Society journal ... electricity through a chemical reaction between a fuel and ...
(Date:11/4/2014)... Fla. (November 4, 2014) — Think about the way ... How do neighboring cells know that they are supposed ... how do these tissues find the correct place and ... answering these crucial questions. , In a new study, ... to communicate with their surrounding neighbors, at the head-trunk ...
(Date:11/4/2014)... HOUSTON – (Nov. 4, 2014) – A majority of ... and that could have serious consequences for the rainforests ... researchers shows the positive impacts lemurs can have on ... impact their disappearance could have on the region,s rich ... rainforest have fruits eaten by lemurs. Lemurs in ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2The inside story: How the brain and skull stay together 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... Five scientists, including two from Simon Fraser University, have ... developing Multiple Sclerosis (MS) can be explained by 475,806 ... commonly screen these variants, looking for genetic links to ... in biology, his thesis supervisor SFU biologist Felix Breden ...
... press release is available in German . ... pointed out that the chemical triclosan is one of ... rivers that are still not sufficiently monitored. With extensive ... more comprehensive than standard monitoring procedures, concentrations of the ...
... and developmental Biology professor Fei Wang and colleagues have ... type of blood stem cell, become the white blood ... tissue damage. This approach offers new insights into the ... improve our ability to treat myeloid diseases like leukemia, ...
Cached Biology News:Scientists deepen genetic understanding of MS 2Triclosan needs to be monitored 2A new technique to study how myeloids become white blood cells 2
... to identify over 150 peptide modifications ... isoforms, protein subsets, and suppress false ... associations and relationships easily. The software ... relative protein expression analysis for discovery ...
... all aspects of classical microscopy in a ... Super Contrast (ASC) objectives coupled with a ... combines flexibility and professional microscopy into one ... the DM-B1 steps into the 21st century ...
... Gene expression profiling allows a high-throuput ... that naturally occuring or artifitially induced changes ... in that system can be detected, studied, ... a broad range of genes at a ...
... agitation and temperature control for microbiology and ... independently and is suitable for DASGIP bioreactors ... volume. Its temperature ranges from approximately 10 ... is equipped with an individual electrical heating ...
Biology Products: